Showing results (1581-1590 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|April 28, 2015
The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myelomaXin Li, Wan-Jun SunOncotargets and Therapy|February 23, 2023
Secondary Sinonasal Collision Tumor of Papillary Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma After Nasopharyngeal Carcinoma Radiotherapy: A Case Report and Literature Review of Sinonasal Collision CarcinomasHao Tang, Lina Wang, Wenfeng Xu, et al.Oncotargets and Therapy|February 28, 2023
Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case ReportMeshaal Alanzi, Mohammad Abu-Tineh, Lajos Szabados, et al.Oncotargets and Therapy|July 30, 2016
Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancerXiao-Ming Xu, Cheng-Gong Wang, Yu-Di Zhu, et al.Oncotargets and Therapy|July 30, 2016
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivoHongming Zhang, Runzhe Chen, Shaoxing Yang, et al.Oncotargets and Therapy|July 30, 2016
Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysisFang-Teng Liu, Qi-Zhen Xue, Pei-Qian Zhu, et al.Oncotargets and Therapy|July 30, 2016
Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinomaPeng Sun, Cui Chen, Fei Zhang, et al.Oncotargets and Therapy|August 2, 2016
Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studiesJiayuan Wu, Liren Hu, Manyu Chen, et al.Oncotargets and Therapy|August 9, 2016
Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studiesKai Bai, Qiucheng Cai, Yi Jiang, et al.Oncotargets and Therapy|August 9, 2016
FAT10 is associated with the malignancy and drug resistance of non-small-cell lung cancerFeng Xue, Lin Zhu, Qing-Wei Meng, et al.Pageof 672